BBLG Q2 2021 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$231,881

Net Income

-$491,898

EPS (Diluted)

$-9.62

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$635,981

Free Cash Flow

-$635,980

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4,438

Total Liabilities

$15M

Stockholders' Equity

-$15M

Cash & Equivalents

$4,438

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$231,881	-$132,709	-74.7%
Net Income	-$491,898	-$380,030	-29.4%